Basal cell carcinoma is the most common malignant neoplasm of the skin, whereas the localization at the nail unit is very rare. We report the case of a 58-year-old patient with a periungual basal cell carcinoma at the thumb. The specific feature of the reported case is the frequent exposure to fishing baits that the patient had stained with an unknown colorant. The use of chromatography, mass spectrometry and infrared spectroscopy revealed the colorant as the azo pigment Solvent Red 8. Solvent Red 8 is a widespread synthetic azo pigment that is applied to stain consumer products. Compounds such as Solvent Red 8 can be cleaved to carcinogenic amines under, for example, light exposure, in particular after incorporation into the human body. As a result of the frequent skin contact to this azo pigment, this hazard compound might have induced the basal cell carcinoma in our patient.

1.
Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1997. CA Cancer J Clin 1997;47:5–27.
2.
Martinelli PT, Cohen PR, Schulze KE, Dorsey KE, Nelson BR: Periungual basal cell carcinoma: case report and literature review. Dermatol Surg 2006;32:320–323.
3.
Galeano M, Lentini M, Stagno D’Alcontres F, Colonna M: Bowenoid basal cell carcinoma of the thumb: a case report and review of the literature. Hand Surg 2002;7:295–298.
4.
Matsushita K, Kawada A, Aragane Y, Tezuka T: Basal cell carcinoma on the right hallux. J Dermatol 2003;30:250–251.
5.
European Commission: Commission directive 2004/93/ec. Official Journal of the European Union 2004;L300/13.
6.
Baumler W, Eibler ET, Hohenleutner U, Sens B, Sauer J, Landthaler M: Q-switch laser and tattoo pigments: first results of the chemical and photophysical analysis of 41 compounds. Lasers Surg Med 2000;26:13–21.
7.
Vasold R, Naarmann N, Ulrich H, Fischer D, Konig B, Landthaler M, Baumler W: Tattoo pigments are cleaved by laser light-the chemical analysis in vitro provide evidence for hazardous compounds. Photochem Photobiol 2004;80:185–190.
8.
Engel E, Santarelli F, Vasold R, Ulrich H, Maisch T, Konig B, Landthaler M, Gopee NV, Howard PC, Baumler W: Establishment of an extraction method for the recovery of tattoo pigments from human skin using HPLC diode array detector technology. Anal Chem 2006;78:6440–6447.
9.
Birnie AJ, Kulkarni K, Varma S: Basal cell carcinoma arising in a tattoo. Clin Exp Dermatol 2006;31:820–821.
10.
Doumat F, Kaise W, Barbaud A, Schmutz JL: Basal cell carcinoma in a tattoo. Dermatology 2004;208:181–182.
11.
Paradisi A, Capizzi R, De Simone C, Fossati B, Proietti I, Amerio PL: Malignant melanoma in a tattoo: case report and review of the literature. Melanoma Res 2006;16:375–376.
12.
Stinco G, De Francesco V, Frattasio A, Quinkenstein E, Patrone P: Malignant melanoma in a tattoo. Dermatology 2003;206:345–346.
13.
Jack C, Adwani A, Krishnan H: Tattoo pigment in an axillary lymph node simulating metastatic malignant melanoma. Int Semin Surg Oncol 2005;2:28.
14.
NTP toxicology and carcinogenesis studies of 2-amino-5-nitrophenol (CAS No. 121-88-0) in F344/N rats and B6C3F1 mice (gavage studies). Natl Toxicol Program Tech Rep Ser 1988;334:1–158.
15.
NTP toxicology and carcinogenesis studies of 2-amino-4-nitrophenol (CAS No. 99-57-0) in F344/N rats and B6C3F1 mice (gavage studies). Natl Toxicol Program Tech Rep Ser 1988;339:1–170.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.